Search Options Stock News and Analysis

https://www.schaeffersresearch.com/content/news/2020/10/07/biopharma-boosted-on-analyst-upgrade

10/7/2020 9:14 AM

The shares of PTC Therapeutics Inc (NASDAQ:PTCT) are up 3.8% at $51.50 in pre-market trading, after J.P. Morgan Securities upgraded the stock to "overweight" from "neutral," with an added price-targe...

2 Drug Stocks That Could Heat Up In July

https://www.schaeffersresearch.com/content/analysis/2018/06/26/2-drug-stocks-that-could-heat-up-in-july

6/26/2018 12:13 PM

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and PTC Therapeutics, Inc. (NASDAQ:PTCT) are two drug stocks struggling today, with the former down 1.5% to trade at $325.28, and the latter down 5.5% to tr...

3 Drug Stocks Trading Near the Top of Nasdaq

https://www.schaeffersresearch.com/content/news/2018/06/18/3-drug-stocks-trading-near-the-top-of-nasdaq

6/18/2018 3:14 PM

Stocks are trading lower, with the Dow down triple digits with less than an hour to go in the session. However, a few names making positive moves today -- all near the top of Nasdaq -- include drug s...

Barclays Downgrade Keeps Pressure On PTC Therapeutics Stock

https://www.schaeffersresearch.com/content/news/2018/04/04/barclays-downgrade-keeps-pressure-on-ptc-therapeutics-stock

4/4/2018 9:47 AM

Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT ) are trading lower this morning after Barclays downgraded the stock to "underweight" from "equal weight" while simultaneously raising its price target t...

PTC Therapeutics Stock Has Room to Keep Running

https://www.schaeffersresearch.com/content/analysis/2018/03/27/ptc-therapeutics-stock-has-room-to-keep-running

3/27/2018 12:02 PM

PTC Therapeutics, Inc. (NASDAQ:PTCT) stock has been red-hot lately, racing to a two-year high of $33.22 last Wednesday. And if a recent volatility signal is any indication, the biotech name could be g...

PEOPLE ALSO SEARCH FOR